David Himmelstein on Medicare Dis-Advantage / Tauhid Chappell on Cannabis Equity
This week on CounterSpin: Headlined “The Cash Monster Was Insatiable,” a 2022 New York Times piece reported insurance companies gaming Medicare Advantage, originally presented as a “low-cost” alternative to traditional Medicare. One company pressed doctors to add additional illnesses to the records of patients they hadn’t seen for weeks: Dig up enough new diagnoses, and … Continued